跳至主要内容
临床试验/NCT01806753
NCT01806753已完成不适用

Performance of Endoscopic Submucosal Dissection According to the Sedation Method

Yonsei University1 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
157
试验地点
1
主要终点
Satisfaction of endoscopists

研究概览

简要总结

Although proper sedation is mandatory for endoscopic procedures such as endoscopic submucosal dissection, the effects of sedation on ESD performance and complications have not been fully evaluated. In the investigators previous retrospective study, en bloc resection and complete resection rates, and procedure time could be improved by sedation with continuous propofol infusion with opioid administration by anesthesiologists. However, there are several limitations to the study including retrospective design. The investigators aimed to evaluate the relationship among sedation methods, satisfaction of endoscopists or patients, clinical outcomes, and complications after endoscopic submucosal dissection for gastric neoplasia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age, between 20 and 80
  • •Early gastric cancer or adenoma, which is indicated by endoscopic submucosal dissection
  • •ECOG performance status 0 or 1
  • •American Society of Anesthesiologist Physical Status 1, 2, or 3

排除标准

  • •Previous subtotal gastrectomy
  • •Previous gastrostomy
  • •Repeated endoscopic submucosal dissection
  • •Three or more synchronous lesions
  • •Allergy to midazolam, propofol, fentanyl, or remifentanil
  • •Pregnancy or breast milk feeding
  • •Active infection
  • •Significant cardiopulmonary disease
  • •Active hepatitis or severe hepatic dysfunction
  • •Severe renal dysfunction
  • •Severe bone marrow dysfunction
  • •Severe neurologic or psychotic disorder

研究组 & 干预措施

midazolam/propofol injection

Experimental

Intermittent midazolam/propofol injection controlled by endoscopist

干预措施: Intermittent midazolam/propofol injection controlled by endoscopist (Procedure)

propofol infusion

Active Comparator

Continuous propofol infusion with opioid administration

干预措施: Continuous propofol infusion with opioid administration (Procedure)

结局指标

主要结局

Satisfaction of endoscopists

时间窗: Within 10 minutes from the end of the endoscopic submucosal dissection

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验